Vol 9, No 2 (2024)
Letter to the Editor
Published online: 2024-06-13

open access

Page views 101
Article views/downloads 70
Get Citation

Connect on Social Media

Connect on Social Media

REASSESSMENT OF THE UNDERLYING MECHANISMS THAT CONTRIBUTE TO THE NEUROLOGICAL DISORDERS LINKED TO LONG-TERM COVID-19

Anna Jaroszewska1, Urantuya Battsengel1, Zofia Zadorozna2
Disaster Emerg Med J 2024;9(2):129-130.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Graban M, Pruc M, Chirico F, et al. Neurological implications of LONG-COVID-19 — current knowledge and the need for implementing remedies. Disaster Emerg Med J. 2024; 9(1): 60–61.
  2. Hampshire A, Azor A, Atchison C, et al. Cognition and memory after COVID-19 in a large community sample. N Engl J Med. 2024; 390(9): 806–818.
  3. Petersen M, Nägele FL, Mayer C, et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2023; 120(22): e2217232120.
  4. Greene C, Connolly R, Brennan D, et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024; 27(3): 421–432 Erratum in: Nat Neurosci. 2024 Apr 16.
  5. Wong AC, Devason AS, Umana IC, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023; 186(22): 4851–4867.e20.
  6. Dziedzic K, Pruc M, Kilic M, et al. Sex- and gender-specific differences in the inflammatory response to COVID-19: the role of the neutrophil-to-lymphocyte ratio. Disaster Emerg Med J. 2023; 8(4): 234–242.
  7. Harris E. Long COVID linked with viral persistence, serotonin decline. JAMA. 2023; 330(19): 1827.
  8. Dziedzic K, Rahnama-Hezavah M, Tomaszewska M, et al. Breaking down the clotting conundrum: analyzing the role of plasma tissue plasminogen activator in COVID-19 patients through a systematic review and meta-analysis. Disaster Emerg Med J. 2023; 8(4): 207–215.